Cystatins: A versatile family

Biomolecular Concepts

Volumn 2, Issue 1-2, 2011, Pages 95-102

  Esposito, Veronica ^a   Temussi, Piero A ^a,b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

aggregation; cystatins; misfolding; sweet proteins; sweet receptor

Indexed keywords

EID: 84874677510     PISSN: 18685021     EISSN: 1868503X     Source Type: Journal    
DOI: 10.1515/bmc.2011.001     Document Type: Review

References (55)

1. Barrett AJ. The cystatins: a diverse superfamily of cysteine peptidase inhibitors. Biomed Biochim Acta 1986; 45: 1363-74.
2. Grubb A, Lofberg H, Barrett AJ. The disulphide bridges of human cystatin C (g-trace) and chicken cystatin. FEBS Lett 1984; 170: 370-4.
3. Brown WM, Dziegielewska KM. Friends and relations of the cystatin superfamily - new members and their evolution. Protein Sci 1997; 6: 5-12.
4. Bennett MJ, Sawaya MR, Eisenberg D. Deposition diseases and 3D domain swapping. Structure 2006; 14: 811-24.
5. Gudmundsson G, Hallgrímsson J, Jónasson TA, Bjarnason O. Hereditary cerebral haemorrhage with amyloidosis. Brain 1972; 95: 387-404.
6. Abrahamson M, Grubb A. Increased body temperature accelerates aggregation of the Leu-68 → Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy. Proc Natl Acad Sci USA 1994; 91: 1416-20.
7. Inglett GE, May JF. Serendipity berries - source of a new intense sweetener. J Food Sci 1969; 34: 408-11.
8. Morris JA. Sweetening agents from natural sources. Lloydia 1976; 39: 25-38.
9. Morris JA, Cagan RH. Purification of monellin, the sweet principle of Dioscoreophyllum cumminsii. Biochim Biophys Acta 1972; 261: 114-22.
10. Bohak Z, Li SL. The structure of monellin and its relation to the sweetness of the protein. Biochim Biophys Acta 1976; 427: 153-70.
11. Bode W, Engh R, Musil D, Thiele U, Huber R, Karshikov A, Brzin J, Kos J, Turk V. The 2.0 Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J 1988; 7: 2593-9.
12. Stubbs MT, Laber B, Bode W, Huber R, Jerala R, Lenarcic B, Turk V. The refined 2.4 Å X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J 1990; 9: 1939-47.
13. Murzin AG. Sweet-tasting protein monellin is related to the cystatin family of thiol proteinase inhibitors. J Mol Biol 1993; 230: 689-94.
14. Spadaccini R, Crescenzi O, Tancredi T, De Casamassimi N, Saviano G, Scognamiglio R, Di Donato A, Temussi PA. Solution structure of a sweet protein: NMR study of MNEI, a single chain monellin. J Mol Biol 2001; 305: 505-14.
15. Koradi R, Billeter M, Wüthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 1996; 14: 29-32.
16. Kim SH, Kang CH, Kim R, Cho JM, Lee YB, Lee TK. Redesigning a sweet protein: increased stability and renaturability. Protein Eng 1989; 2: 571-5.
17. Tancredi T, Iijima H, Saviano G, Amodeo P, Temussi PA. Structural determination of the active site of a sweet protein. A 1H NMR investigation of pMNEI. FEBS Lett 1992; 310: 27-30.
18. Somoza JR, Jiang F, Tong L, Kang CH, Cho JM, Kim SH. Two crystal structures of a potently sweet protein. Natural monellin at 2.75 Å resolution and single-chain monellin at 1.7 Å resolution. J Mol Biol 1993; 234: 390-404.
19. Hung LW, Kohmura M, Ariyoshi Y, Kim SH. Structure of an enantiomeric protein, D-monellin at 1.8 Å resolution. Acta Crystallogr D Biol Crystallogr 1998; 54: 494-500.
20. Lee SY, Lee JH, Chang HJ, Cho JM, Jung JW, Lee W. Solution structure of a sweet protein single-chain monellin determined by nuclear magnetic resonance and dynamical simulated annealing calculations. Biochemistry 1999; 38: 2340-6.
21. Kim SH, Kang C-H, Cho JM. Sweet proteins, biochemical studies and genetic engineering. In: Walters DE, Orthofer FT, DuBois GE, editors. Sweeteners, discovery, molecular design and chemoreception, Vol. 450. Washington DC: ACS Symposium Series, ACS 1991: 28-40.
22. Tancredi T, Pastore A, Salvadori S, Esposito V, Temussi PA. Interaction of sweet proteins with their receptor. A conformational study of peptides corresponding to loops of brazzein, monellin and thaumatin. Eur J Biochem 2004; 271: 2231-40.
23. Temussi PA. Why are sweet proteins sweet? Interaction of brazzein, monellin and thaumatin with the T1R2-T1R3 receptor. FEBS Lett 2002; 526: 1-4.
24. Morini G, Bassoli A, Temussi PA. From small sweeteners to sweet proteins: anatomy of the binding sites of the human T1R2-T1R3 receptor. J Med Chem 2005; 48: 5520-9.
25. Temussi PA. Natural sweet macromolecules: how sweet proteins work. Cell Mol Life Sci 2006; 63: 1876-88.
26. Li X, Staszewski L, Xu H, Durick K, Zoller M, Adler E. Human receptors for sweet and umami taste. Proc Natl Acad Sci USA 2002; 99: 4692-6.
27. Xu H, Staszewski L, Tang H, Adler E, Zoller M, Li X. Different functional roles of T1R subunits in the heteromeric taste receptors. Proc Natl Acad Sci USA 2004; 101: 14258-63.
28. Esposito V, Temussi PA. Food acceptance and protein taste. Flavour Fragrance J in press.
29. Holm L, Sander C. Dali: a network tool for protein structure comparison. Trends Biochem Sci 1995; 20: 478-80.
30. Nagata K, Kudo N, Abe K, Arai S, Tanokura M. Three-dimensional solution structure of oryzacystatin-I, a cysteine proteinase inhibitor of the rice, Oryza sativa L. japonica. Biochemistry 2000; 39: 14753-60.
31. Abrahamson M, Ritonja A, Brown MA, Grubb A, Machleidt W, Barrett AJ. Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. J Biol Chem 1987; 262: 9688-94.
32. Carrell RW, Lomas DA. Conformational disease. Lancet 1997; 350: 134-8.
33. Temussi PA, Masino L, Pastore A. From Alzheimer to Huntington: why is a structural understanding so difficult? EMBO J 2003; 22: 355-61.
34. Ross CA, Poirier MA. What is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol 2005; 6: 891-8.
35. Caughey B, Lansbury PT. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 2003; 26: 267-98.
36. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-6.
37. Ceru S, Rabzelj S, Kopitar-Jerala N, Turk V, Zerovnik E. Protein aggregation as a possible cause for pathology in a subset of familial Unverricht-Lundborg disease. Med Hypotheses 2005; 64: 955-9.
38. Knaus KJ, Morillas M, Swietnicki W, Malone M, Surewicz WK, Yee VC. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol 2001; 8: 770-4.
39. Levy E, Jaskolski M, Grubb A. The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models. Brain Pathol 2006; 16: 60-70.
40. Mi W, Pawlik M, Sastre M, Jung SS, Radvinsky DS, Klein AM, Sommer J, Schmidt SD, Nixon RA, Mathews PM, Levy E. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models. Nat Genet 2007; 39: 1440-2.
41. Kaeser SA, Herzig MC, Coomaraswamy J, Kilger E, Selenica ML, Winkler DT, Staufenbiel M, Levy E, Grubb A, Jucker M. Cystatin C modulates cerebral β-amyloidosis. Nat Genet 2007; 39: 1437-9.
42. Del Boccio P, Pieragostino D, Lugaresi A, Di Ioia M, Pavone B, Travaglini D, D'Aguanno S, Bernardini S, Sacchetta P, Federici G, Di Ilio C, Gambi D, Urbani A. Cleavage of cystatin C is not associated with multiple sclerosis. Ann Neurol 2007; 62: 201-4.
43. Bjarnadottir M, Nilsson C, Lindström V, Westman A, Davidsson P, Thormodsson F, Blöndal H, Gudmundsson G, Grubb A. The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids. Amyloid 2001; 8: 1-10.
44. Jaskolski M. 3D domain swapping, protein oligomerization, and amyloid formation. Acta Biochim Pol 2001; 48: 807-27.
45. Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M, Jaskolski M. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol 2001; 8: 316-20.
46. Janowski R, Abrahamson M, Grubb A, Jaskolski M. Domain swapping in N-truncated human cystatin C. J Mol Biol 2004; 341: 151-60.
47. Bennett MJ, Choe S, Eisenberg D. Domain swapping: entangling alliances between proteins. Proc Natl Acad Sci USA 1994; 91: 3127-31.
48. Joensuu T, Lehesjoki AE, Kopra O. Molecular background of EPM1-Unverricht-Lundborg disease. Epilepsia 2008; 49: 557-63.
49. Kordis D, Turk V. Phylogenomic analysis of the cystatin superfamily in eukaryotes and prokaryotes. BMC Evol Biol 2009; 9: 266.
50. Jenko Kokalj S, Guncar G, Stern I, Morgan G, Rabzelj S, Kenig M, Staniforth RA, Waltho JP, Zerovnik E, Turk D. Essential role of proline isomerization in stefin B tetramer formation. J Mol Biol 2007; 366: 1569-79.
51. Kenig M, Berbić S, Krijestorac A, Kroon-Zitko L, Tusek M, Pompe-Novak M, Zerovnik E. Differences in aggregation properties of three site-specific mutants of recombinant human stefin B. Protein Sci 2004; 13: 63-70.
52. Konno T, Murata K, Nagayama K. Amyloid-like aggregates of a plant protein: a case of a sweet-tasting protein, monellin. FEBS Lett 1999; 454: 122-6.
53. Konno T. Multistep nucleus formation and a separate subunit contribution of the amyloidgenesis of heat-denatured monellin. Protein Sci 2001; 10: 2093-101.
54. Esposito V, Guglielmi F, Martin SR, Pauwels K, Pastore A, Piccoli R, Temussi PA. Aggregation mechanisms of cystatins: a comparative study of monellin and oryzacystatin. Biochemistry 2010; 49: 2805-10.
55. Carrell R, Travis J. α1-Antitrypsin and the serpins: variation and countervariation. Trends Biochem Sci 1985; 10: 20-4.